AAL three-lens brief
Evidence-based stock research on AAL. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $14.86 — 24% above current (24 analysts).
- Analyst mean target $14.86 — 24% above current (24 analysts).
- 10-Q filing filed 2026-04-23.
AAL closed at $11.99 (+1.23%) as of 2026-05-04. Market cap: $7.93B. P/E (trailing) 38.7. Positives: analyst mean target $14.86 — 24% above current (24 analysts).. Last quarter: Revenue $13.91B, net income -$382.00M, free cash flow $861.12M.
Why three lenses on AAL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AALacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AAL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AAL brief"></iframe>